Physician Wealth Advisors’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
Physician Wealth Advisors's ADVM Position: Q4 2025 in Review
Physician Wealth Advisors sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 217 shares — an estimated $984 sold.
Physician Wealth Advisors first reported a position in ADVM in Q3 2025 and held it in 1 quarter. The position peaked at $984 in Q3 2025. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Physician Wealth Advisors reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Physician Wealth Advisors sold 217 Adverum Biotechnologies shares in Q4 2025, an estimated $984.
- Physician Wealth Advisors first reported a position in Adverum Biotechnologies in Q3 2025 and held it in 1 quarter.
- Physician Wealth Advisors's Adverum Biotechnologies position peaked at $984 in Q3 2025.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.